Select Medical Gets a Buy Rating from RBC Capital

By Austin Angelo

In a report released yesterday, Frank Morgan from RBC Capital reiterated a Buy rating on Select Medical (NYSE: SEM), with a price target of $19. The company’s shares opened today at $17.75.

According to TipRanks.com, Morgan is a 4-star analyst with an average return of 7.9% and a 53.4% success rate. Morgan covers the Services sector, focusing on stocks such as AmerisourceBergen Corporation, Fresenius Medical Care Corp, and Quest Diagnostics Inc.

Select Medical has an analyst consensus of Moderate Buy, with a price target consensus of $18.

Based on Select Medical’s latest earnings report for the quarter ending June 30, the company posted quarterly revenue of $1.12 billion and quarterly net profit of $40.71 million. In comparison, last year the company earned revenue of $1.05 billion and had a net profit of $6.26 million.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Select Medical Holdings Corp. engages in the provision of medical rehabilitation services. It operates through the following segments: Specialty Hospitals, Outpatient Rehabilitation, and Concentra. The Specialty Hospitals segment involves in providing long term acute care hospital services and inpatient acute rehabilitative hospital care.